Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mediascan59on Nov 30, 2010 3:24pm
253 Views
Post# 17778566

RE: RE: Something to consider

RE: RE: Something to considerSTCKGUY,
Show me the post where I told you I rode epo and ppi up for  two months. As per efg, I first entered it at .30 and although I do not recall  the price when I mentioned it here being .36...but I will take it that  it is accurate, I believe it  went to .44 after that, and  since then found out why it was  sold off at that time.
As per tax loss selling, I didn't respond to you because  first of all  I didn't feel I needed too, and second, because I felt that most  were....are in a profit position  with  this play above .30, so there is not  "tax selling" to take advantage of with efg...and that was....is very obvious to me.
Next?...
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse